Tissue Engineering of Vascular Prosthetic Grafts
|
Email this
Print this
Peter Zilla
List price: $200.00 |
About this bookThis book is about the perfect vascular graft: A hypothetical discussion of what it is and how one may go about producing it.. By exploring some basic biological areas and introducing the background of clinical and pathological failures and demands, this book shall serve as a comprehensive guide, furthering the research initiatives of academic vascular surgeons, scientists and industry researchers. |
|
Table of contents1. The Lack of Healing in Conventional Vascular Grafts 2. Noncompliance: The Silent Acceptance of a Villain 3. Endothelial Cell Seeding: A Review 4. Surface Precoating in the 1980s: A First Taste of Cell-Matrix Interactions 5. Surface Precoating in the 1990s: The Fine Tuning of Endothelial Cell
Transplantaion 6. Microvascular Endothelial Cell Transplantation: A Review 7. Morphological Aspects of Microvascular Cell Isolates 8. Functional Aspects of Microvascular Cell Isolates 9. Automated Seeding Device 10. Healing Patterns Following Microvascular Cell Seeding -A Clinical Evaluation
of Microvascular-Seeded A-V Access Grafs 11. Neointimal Hyperplasia in Small-Diameter Prosthetic Vascular Grafts:
Influence of Endothelial Cell Seeding with Microvascular Omental Cells in a
Canine Model 12. Human Clinical Trials of Microvascular Endothelial Cell Sodding 13. In Vitro Endothelialization: Its Contribution Towards an Ideal Vascular
Replacement 14. Serial Cultivation of Human Endothelial Cells 15. Risk Factors for Autologous Endothelial Cell Cultures 16. Adhesion Molecule Expression Following In Vitro Lining 17. In Vitro Endothelialization Elicits Tissue Remodelling Emulating Native
Artery Structures 18. In Vitro Endothelialization of Synthetic Vascular Grafts in Long Term
Clinical Use 19. Inflammatory Reaction: The Nemesis of Implants 20. Molecular Determinants of Acute Inflammatory Responses to Biomaterials 21. The Accumulation of Inflammatory Mediators: A Target for the Prevention
of Fibrosis 22. Pathobiology of Hyperplastic Intimal Responses 23. Cell Cycle Interruption to Inhibit Neointimal Hyperplasia Facilitation
of Healing 24. Signaling Mechanisms for Vascular Cell Migration 25. Adhesion Molecules: Potent Inducers of Endothelial Cell Chemotaxis 26. Angiogenesis in Tissues and Vascular Grafts 27. Polypeptide Growth Factors with a Collagen Binding Domain: Their Potential
for Tissue Repair and Organ Regeneration 28. Fibroblast Growth Factors in Angiogenesis and Tissue Engineering 29. Role of Urokinase-Type Plasminogen Activator (u-PA) in In Vitro Angiogenesis
in Fibrin Matrices 30. How Does Extracellular Matrix Control Capillary Morphogenesis? 31. Collagen Matrices Attenuate Fibroblast Response to TGF-b 32. Extracellular Matrix Proteins are Potent Agonists of Human Smooth Muscle
Migration 33. Extracellular Matrix Effect on Endothelial Control of Smooth Muscle
Cell Migration and Matrix Synthesis 34. Circulating Stem Cells: A Fourth Source for the Endothelialization
of Cardiovasculr Implants 35. Surface Population with Blood-Borne Cells 36. Cellular Population of the Textured-Surface Left Ventricular Assist
Devices Leads to Sustained Activation of a Procoagulant and Proinflammatory
Systemic Response 37. Transdifferentiation and the Vascular Wall 38. Endothelial Cells Transformed from Fibroblasts During Angiogenesis 39. Mechanical Forces and Cell Differentiation 40. An Integral Mathematical Apporach to Tissue Engineering of Vascular
Grafts 41. Bioinertness: An Outdated Principle 42. Bioinert Materials: Are Their Properties Irreplaceable? 43. Biostable Polymers as Durable Scaffolds for Tissue Engineered Vascular
Prostheses 44. Biophilic Polymers: What\\\'s on the Horizon? 45. Bioresorblable Grafts: A Counterintuitive Approach 46. Biodegradable Materials 47. The Influence of Porosity and Surface Roughness on Biocompatibility 48. Microgroove Driven Tissue Ingrowth 49. Surface Bonding of Heparin 50. Covalent Grafting of RGD Peptides to Synthetic Surfaces 51. Hydrogels in Biological Control During Graft Healing 52. In Vivo Synthesis of Organs Using Collagen-GAG Copolymers 53. Artificial Extracellular Matrix Proteins for Graft Design 54. Cell-Extracellular Matrix Interactions Relevant to Vascular Tissue
Engineering 55. Use of Hydroxypropylchitosan Acetate as a Carrier for Growth Factor
Release 56. Transplantation of Transduced Smooth Muscle Cells: A Vehicle for Local
and Systemic Gene Therapy |
|
Email this
Print this